Back to Trades
Sell4
Maze Therapeutics, Inc.
MAZE
Total Value
$2.8M
Net $1.8M sold
Sales
$1.8M
2 transactions
Company Information
- Company Name
- Maze Therapeutics, Inc.
- Ticker Symbol
- MAZE
- CIK
- 0001842295
Insider Information
- Name
- Bernstein Harold
- Role
- Insider
- Location
- SOUTH SAN FRANCISCO, CA
Filing Details
- Filing Date
- Dec 31, 2025
- Transaction Date
- Dec 29, 2025
- Accession Number
- 0002050172-25-000007
- Form Type
- 4
- Net Trading Amount
- -$1.8M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Dec 29, 2025 | Common Stock | 45,000 | $10.42 | Exercise | $468.9K |
| Dec 29, 2025 | Common Stock | 27,800 | $40.34 | Sale | $1.1M |
| Dec 29, 2025 | Common Stock | 17,200 | $40.93 | Sale | $703.9K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Dec 29, 2025 | Derivative | 45,000 | $10.42 | Exercise | $468.9K |
Footnotes
- (F1)This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.
- (F2)The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.71 to $40.705 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 3 of this Form 4.
- (F3)The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.73 to $41.51 per share, inclusive.
- (F4)The option vested as to 1/4th of the total award on October 3, 2023, and thereafter vested or vests as to 1/48th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.